Business Description

Bormioli Pharma, a primary manufacturer of plastic and glass packaging for the pharmaceutical, nutraceutical, and biopharmaceutical markets is Bormioli Pharma. Products include dual-chamber systems and are geared towards drug delivery for nasal, parenteral, and oral use. Bormioli Pharma was established in 2017 when the London-based investment firm Triton Investments Advisers LLP acquired the pharma division of Bormioli Rocco, a glass manufacturer. Luigi Bormioli SpA also acquired Bormioli Rocco’s glass tableware business from Vision Capital.

Key Financials

Revenue (US$ Mn)

Operating Income (US$ Mn)

Net Income (US$ Mn)

Operating Margin %

Gross Margin %

SWOT Analysis

Strengths

Get this premium content

The Premium data is Locked

Buy Now to Unlock Premium Data

Request Sample Data